To exclude off-target drug effects as contributary factors driving our observations, we exposed fully differentiated CD8+ T-cells from female Lxrα knockout mice (Nr1h3−/−) and wildtype littermate controls (Nr1h3+/+) to TCM and tumor antigens and profiled their mitochondrial activity and glycolytic output as before. This evidence concerns the gene NR1H3 and neoplasm.